Skip to main content
Journal cover image

Reversal of a dabigatran overdose: what are possible options?

Publication ,  Journal Article
Ratanapo, S; Ungprasert, P; Srivali, N; Cheungpasitporn, W; Bischof, EF
Published in: Am J Med Sci
September 2013

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Am J Med Sci

DOI

EISSN

1538-2990

Publication Date

September 2013

Volume

346

Issue

3

Start / End Page

259

Location

United States

Related Subject Headings

  • beta-Alanine
  • Renal Dialysis
  • Recombinant Proteins
  • Prothrombin
  • Humans
  • Hemorrhage
  • General & Internal Medicine
  • Factor VIIa
  • Dabigatran
  • Coagulants
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ratanapo, S., Ungprasert, P., Srivali, N., Cheungpasitporn, W., & Bischof, E. F. (2013). Reversal of a dabigatran overdose: what are possible options? Am J Med Sci, 346(3), 259. https://doi.org/10.1097/MAJ.0b013e318295cc72
Ratanapo, Supawat, Patompong Ungprasert, Narat Srivali, Wisit Cheungpasitporn, and Edward F. Bischof. “Reversal of a dabigatran overdose: what are possible options?Am J Med Sci 346, no. 3 (September 2013): 259. https://doi.org/10.1097/MAJ.0b013e318295cc72.
Ratanapo S, Ungprasert P, Srivali N, Cheungpasitporn W, Bischof EF. Reversal of a dabigatran overdose: what are possible options? Am J Med Sci. 2013 Sep;346(3):259.
Ratanapo, Supawat, et al. “Reversal of a dabigatran overdose: what are possible options?Am J Med Sci, vol. 346, no. 3, Sept. 2013, p. 259. Pubmed, doi:10.1097/MAJ.0b013e318295cc72.
Ratanapo S, Ungprasert P, Srivali N, Cheungpasitporn W, Bischof EF. Reversal of a dabigatran overdose: what are possible options? Am J Med Sci. 2013 Sep;346(3):259.
Journal cover image

Published In

Am J Med Sci

DOI

EISSN

1538-2990

Publication Date

September 2013

Volume

346

Issue

3

Start / End Page

259

Location

United States

Related Subject Headings

  • beta-Alanine
  • Renal Dialysis
  • Recombinant Proteins
  • Prothrombin
  • Humans
  • Hemorrhage
  • General & Internal Medicine
  • Factor VIIa
  • Dabigatran
  • Coagulants